Joe Biden Diagnosed with Aggressive Prostate Cancer; Trump Responds with Sympathy and Scrutiny
On May 18, 2025, former President Joe Biden’s office announced that he has been diagnosed with an aggressive form of prostate cancer that has metastasized to his bones. The diagnosis followed a routine physical prompted by urinary symptoms, revealing a Gleason score of 9, indicating a highly aggressive cancer.
Despite the severity, the cancer is hormone-sensitive, allowing for effective management, and Biden and his family are currently reviewing treatment options with his physicians.
President Donald Trump initially expressed sympathy, stating, “Melania and I are saddened to hear about Joe Biden’s recent medical diagnosis. We extend our warmest and best wishes to Jill and the family, and we wish Joe a fast and successful recovery.”
However, Trump later questioned the timing of the public disclosure, expressing surprise that the diagnosis wasn’t revealed earlier. He suggested that the public “wasn’t informed” about Biden’s medical situation and implied that there might have been a lack of transparency regarding the former president’s health during his tenure.
The diagnosis has sparked discussions about the importance of transparency in public officials’ health disclosures and the potential implications for public trust. As Biden considers his treatment options, the nation watches closely, reflecting on the broader issues of health, leadership, and accountability.